956 results match your criteria Travel Medicine and Vaccination


Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children.

Vaccines (Basel) 2019 Feb 4;7(1). Epub 2019 Feb 4.

Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia.

We investigated the immunogenicity, seroprotection rates and persistence of immune memory in young children at high risk of pneumococcal disease in Papua New Guinea (PNG). Children were primed with 10-valent (PCV10) or 13-valent pneumococcal conjugate vaccines (PCV13) at 1, 2 and 3 months of age and randomized at 9 months to receive PPV (PCV10/PPV-vaccinated, n = 51; PCV13/PPV-vaccinated, n = 52) or no PPV (PCV10/PPV-naive, n = 57; PCV13/PPV-naive, n = 48). All children received a micro-dose of PPV at 23 months of age to study the capacity to respond to a pneumococcal challenge. Read More

View Article

Download full-text PDF

Source
http://www.mdpi.com/2076-393X/7/1/17
Publisher Site
http://dx.doi.org/10.3390/vaccines7010017DOI Listing
February 2019
2 Reads

Shortage of yellow fever vaccination: A travel medicine emergency for Chilean travellers.

Travel Med Infect Dis 2019 Jan 29. Epub 2019 Jan 29.

Centro de Epidemiología y Políticas de Salud, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2019.01.016DOI Listing
January 2019

Vaccinations in kidney transplant recipients: Clearing the muddy waters.

World J Transplant 2019 Jan;9(1):1-13

Divisions of Nephrology and Hypertension, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA 15212, United States.

Vaccine preventable diseases account for a significant proportion of morbidity and mortality in transplant recipients and cause adverse outcomes to the patient and allograft. Patients should be screened for vaccination history at the time of pre-transplant evaluation and vaccinated at least four weeks prior to transplantation. For non-immune patients, dead-vaccines can be administered starting at six months post-transplant. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5500/wjt.v9.i1.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347668PMC
January 2019
1 Read

[Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group].

Acta Med Port 2018 Dec 28;31(12):724-729. Epub 2018 Dec 28.

Unidade de Saúde Pública. Agrupamento de Centros de Saúde Loures-Odivelas. Loures. Instituto de Medicina Preventiva e Saúde Pública. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.

Introduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization. Read More

View Article

Download full-text PDF

Source
https://actamedicaportuguesa.com/revista/index.php/amp/artic
Publisher Site
http://dx.doi.org/10.20344/amp.10309DOI Listing
December 2018
5 Reads

Arguments for a two-dose yellow fever vaccination regimen in travellers.

J Travel Med 2019 Jan 18. Epub 2019 Jan 18.

Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jtm/taz004DOI Listing
January 2019
1 Read

Baseline HPV prevalence in rectal swabs from men attending a sexual health clinic in Scotland: assessing the potential impact of a selective HPV vaccination programme for men who have sex with men.

Sex Transm Infect 2019 Jan 13. Epub 2019 Jan 13.

Health Protection Scotland, Glasgow, UK.

Objectives: A human papillomavirus (HPV) vaccination programme targeted towards men who have sex with men who are disproportionately affected by HPV anogenital infection and related disease was established in Scotland in July 2017. We aimed to establish a baseline HPV prevalence to assess the potential impact of the programme.

Methods: Residual rectal swabs taken in a sexual health clinic (n=1 248) were tested for the presence of HPV and HPV-type prevalence was collated and stratified by age. Read More

View Article

Download full-text PDF

Source
http://sti.bmj.com/lookup/doi/10.1136/sextrans-2018-053668
Publisher Site
http://dx.doi.org/10.1136/sextrans-2018-053668DOI Listing
January 2019
10 Reads

T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Int Rev Cell Mol Biol 2019 24;342:175-263. Epub 2018 Oct 24.

Department of Medicine, McGill University, Montréal, QC, Canada; Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.

Continuous epidemiological surveillance of existing and emerging viruses and their associated disorders is gaining importance in light of their abilities to cause unpredictable outbreaks as a result of increased travel and vaccination choices by steadily growing and aging populations. Close surveillance of outbreaks and herd immunity are also at the forefront, even in industrialized countries, where previously eradicated viruses are now at risk of re-emergence due to instances of strain recombination, contractions in viral vector geographies, and from their potential use as agents of bioterrorism. There is a great need for the rational design of current and future vaccines targeting viruses, with a strong focus on vaccine targeting of adaptive immune effector memory T cells as the gold standard of immunity conferring long-lived protection against a wide variety of pathogens and malignancies. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19376448183008
Publisher Site
http://dx.doi.org/10.1016/bs.ircmb.2018.07.006DOI Listing
October 2018
9 Reads

Perspectives and preferences for a mobile health tool designed to facilitate HPV vaccination among young men who have sex with men.

Hum Vaccin Immunother 2019 Jan 9:1-9. Epub 2019 Jan 9.

e Section of Adolescent Medicine , Indiana University School of Medicine , Indianapolis , IN , USA.

We sought to understand young men who have sex with men (YMSM) perspectives and preferred features for a mobile health (mHealth) tool designed to facilitate human papillomavirus (HPV) vaccination. YMSM were recruited on a popular social/sexual networking app to participate in online focus groups. Discussions were designed to elicit what the men would want in a mHealth tool specific for sexual health and HPV. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/21645515.2019.1
Publisher Site
http://dx.doi.org/10.1080/21645515.2019.1568156DOI Listing
January 2019
4 Reads

Infectious Disease: Community Response to Emerging Infectious Diseases.

FP Essent 2019 Jan;476:25-29

University of South Dakota Sanford School of Medicine Department of Family Medicine, 414 E. Clark Street, Vermillion, SD 57069.

Emerging infectious diseases are those that are newly discovered, recently have increased in prevalence, or are expected to increase in prevalence in the future. Family physicians play an important role in leading community response to emerging infectious diseases. As with other types of disasters, the general approach to outbreaks has four stages: preparedness, response, recovery, and mitigation. Read More

View Article

Download full-text PDF

Source
January 2019
4 Reads

Q fever vaccination of children in Australia: Limited experience to date.

J Paediatr Child Health 2019 Jan 2. Epub 2019 Jan 2.

Infection Management and Prevention Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia.

Aim: Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii and is associated with significant morbidity and mortality in both adults and children. Australia is the only country that has produced and registered a Q fever vaccine for human use, but this vaccine is licenced only for people aged over 15 years as data and experience in children are limited. This review describes the experience of Q fever vaccination of known paediatric cases in Australia to date. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpc.14364DOI Listing
January 2019
3 Reads

Getting to the heart of influenza vaccination in winter travellers.

J Travel Med 2019 Jan;26(1)

School of Medicine, National University of Ireland Galway, Galway, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jtm/tay158DOI Listing
January 2019

Travel medicine consultation: An opportunity to improve coverage for routine vaccinations.

Med Mal Infect 2018 Dec 21. Epub 2018 Dec 21.

Service des maladies infectieuses et tropicales, Centre de vaccinations internationales et conseils aux voyageurs, CHU de Saint-Étienne, 42055 Saint-Étienne, France; Inserm, CIC 1408, 42055 Saint-Étienne, France; Inserm, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), 75679 Paris, France; Groupe immunité des muqueuses et agents Pathogènes - GIMAP EA 3064, université de Saint-Étienne, Université de Lyon, 42270 Saint-Priest-en-Jarez, France.

Background: Travelers may be responsible for the spread of vaccine-preventable diseases upon return. Travel physicians and family physicians may play a role in checking and updating vaccinations before traveling. Our aim was to evaluate the vaccine coverage for mandatory and recommended vaccination in travelers attending a travel medicine clinic (TMC). Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0399077X173085
Publisher Site
http://dx.doi.org/10.1016/j.medmal.2018.11.008DOI Listing
December 2018
7 Reads

Multidisciplinary Collaboration between a Community Pharmacy and a Travel Clinic in a Swiss University Primary Care and Public Health Centre.

Pharmacy (Basel) 2018 Dec 5;6(4). Epub 2018 Dec 5.

Community Pharmacy Centre, Department of Ambulatory Care and Community Medicine, University of Lausanne, CH-1011 Lausanne, Switzerland.

This review is a narrative description of a collaboration between a travel clinic and a community pharmacy centre within a university primary care and public health centre (Lausanne/Switzerland). Pharmacists and pharmacy technicians participate in this collaboration to provide (1). counselling and clinical activities with travellers (e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/pharmacy6040126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306721PMC
December 2018

Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium.

Glob Health Action 2018 ;11(1):1549930

a Unit of Epidemiology and Global Health, Department of Public Health and Clinical Medicine , Umeå University , Umeå , Sweden.

Background: Dengue fever persists as a major global disease burden, and may increase as a consequence of climate change. Along with other measures, research actions to improve diagnosis, surveillance, prevention, and predictive models are highly relevant. The European Commission funded the DengueTools consortium to lead a major initiative in these areas, and this review synthesises the outputs and findings of this work conducted from 2011 to 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/16549716.2018.1549930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282436PMC
January 2018
2 Reads

Prevalence of geophagy and knowledge about its health effects among native Sub-Saharan Africa, Caribbean and South America healthy adults living in France.

Eat Weight Disord 2018 Dec 13. Epub 2018 Dec 13.

Service de Médecine Interne et des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Reims, 51092, Reims, France.

Geophagy is widespread among women from Sub-Saharan Africa, South America and the Caribbean and may persist in western countries. This practice may be associated with adverse effects such as anaemia, constipation or intestinal occlusion. We aimed to determine the prevalence of geophagy and the level of knowledge about its health effects among healthy adults originating from these countries and attending a travel medicine and international vaccination consultation in France. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40519-018-0624-9
Publisher Site
http://dx.doi.org/10.1007/s40519-018-0624-9DOI Listing
December 2018
7 Reads

Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review.

Infect Dis Health 2019 Feb 26;24(1):13-22. Epub 2018 Oct 26.

Division of Infectious Diseases, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.

Background: Immunocompromised travelers (ICTs) are medically complex and challenging for travel medicine providers. Our study hypothesizes that ICTs have high-risk travel itineraries and do not have adequate immunity against vaccine-preventable infections.

Methods: This retrospective review of 321 ICTs from 2004 to 2015 included patients with solid organ transplant (SOT, n = 134), connective tissue disease (CTD, n = 121), inflammatory bowel disease (IBD, n = 46), and human immunodeficiency virus (HIV, n = 20). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.idh.2018.09.083DOI Listing
February 2019

An Educational Intervention to Improve HPV Vaccination: A Cluster Randomized Trial.

Pediatrics 2019 Jan 10;143(1). Epub 2018 Dec 10.

Regenstrief Institute Center for Biomedical Informatics, Indianapolis, Indiana.

: media-1vid110.1542/5849572217001PEDS-VA_2018-1457 BACKGROUND: Human papillomavirus (HPV) infection can lead to serious health issues and remains the most common sexually transmitted infection. Despite availability of effective vaccines, HPV vaccination rates are suboptimal. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2018-1457DOI Listing
January 2019

Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review.

Travel Med Infect Dis 2018 Dec 4. Epub 2018 Dec 4.

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), Service de Santé des Armées (SSA), Microbes Vecteurs Infections Tropicales et Méditerranéennes (VITROME), Institut Hospitalo-Universitaire-Méditerranée Infection (IHU-Méditerranée Infection), Marseille, France. Electronic address:

Background: The Islamic Hajj pilgrimage to Mecca is one of the world's largest annual mass gatherings. Inevitable overcrowding during the pilgrims' stay greatly increases the risk of acquiring and spreading infectious diseases, especially respiratory diseases.

Method: The MEDLINE/PubMed and Scopus databases were searched for all relevant papers published prior to February 2018 that evaluated the prevalence of clinical symptoms of respiratory infections, including pneumonia, among Hajj pilgrims, as well as their influenza and pneumococcal vaccination status. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2018.12.002DOI Listing
December 2018
3 Reads
1.538 Impact Factor

A cross-sectional study to assess the awareness and practices related to adult immunization among nursing students in a metropolitan city.

J Educ Health Promot 2018 29;7:129. Epub 2018 Oct 29.

Department of Community Medicine, Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India.

Introduction: Immunization against vaccine-preventable diseases in adults is the need of the hour. The student nurses by virtue of training are the frontline health workers dealing with patient care. They are exposed to maximum risk of contracting the diseases. Read More

View Article

Download full-text PDF

Source
http://www.jehp.net/text.asp?2018/7/1/129/244389
Publisher Site
http://dx.doi.org/10.4103/jehp.jehp_55_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225393PMC
October 2018
12 Reads

Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation.

Vaccine 2019 Jan 27;37(3):510-515. Epub 2018 Nov 27.

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, 1105AZ Amsterdam, the Netherlands. Electronic address:

Infection with Streptococcus pneumoniae is a life-threatening, but vaccine preventable complication in patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT). The international consensus on post allo-HSCT immunization schedules, starting 3-6 months after HSCT, focuses on short-term immunogenicity while long-term immunogenicity is not well characterized. The current Dutch immunization schedule, which starts at 12 months post allo-HSCT, was developed as a result of concerns on the coverage of long-term immunogenicity in international guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2018.11.053DOI Listing
January 2019
1 Read

The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland.

Pharmacy (Basel) 2018 Nov 29;6(4). Epub 2018 Nov 29.

Community Pharmacy Centre, Department of Ambulatory Care and Community Medicine, University of Lausanne, CH-1011 Lausanne, Switzerland.

This review presents the Swiss strategy initiated over the last several years to implement vaccination by community pharmacists. National health authorities aimed to integrate community pharmacists in the National Vaccination Strategy (NVS) in order to increase the vaccination rate in the Swiss population. To support this aim, universities and the Swiss Association of Pharmacists developed pre- and post-graduate education programmes on vaccination for pharmacists. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/pharmacy6040125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306781PMC
November 2018
2 Reads

Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol.

BMC Infect Dis 2018 Dec 3;18(1):605. Epub 2018 Dec 3.

University of Texas McGovern Medical School and School of Public Health, 1200 Pressler Street, Houston, TX, 77030, USA.

Background: Acute gastroenteritis (AGE) is the leading cause of illness among returning travelers seeking medical care. Multiple types of enteric pathogens can cause travel-acquired AGE and, while bacterial pathogens have a predominant role, the importance of viruses, such as norovirus, is increasingly recognized. There is a lack of information on travel-acquired norovirus incidence among symptomatic and asymptomatic individuals irrespective of healthcare-seeking behavior. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-018-3461-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276235PMC
December 2018
2 Reads

Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.

Ann Intern Med 2018 Dec 27;169(11):761-765. Epub 2018 Nov 27.

Leiden University Medical Center, Leiden, the Netherlands (K.V., A.W.D., L.G.V.).

Background: Outbreaks of yellow fever and a frequently depleted vaccine stock increase demand for a dose-sparing strategy. A fractional dose of 17D yellow fever virus (17D-YFV) vaccine has been shown to be noninferior to the standard dose in inducing seroprotection.

Objective: To evaluate whether fractional-dose vaccination can confer long-term immunity. Read More

View Article

Download full-text PDF

Source
http://annals.org/article.aspx?doi=10.7326/M18-1529
Publisher Site
http://dx.doi.org/10.7326/M18-1529DOI Listing
December 2018
1 Read

Perceptions of rabies risk: a survey of travellers and travel clinics from Canada, Germany, Sweden and the UK.

J Travel Med 2019 Feb;26(Supplement_1):S3-S9

Department of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.

Background: Extensive global experience shows that rabies pre-exposure prophylaxis (PrEP) through vaccination is effective and well tolerated, yet many travellers opt not to be vaccinated when travelling to rabies-endemic countries. Previous research has identified several factors influencing the choices travellers make to reduce the risk of rabies, including cost, time constraint and perspective on the importance of vaccination. The objectives of this study were to assess travellers' awareness of rabies and advice-seeking attitudes and to evaluate travel clinics practices regarding rabies pre-travel advice. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm
Publisher Site
http://dx.doi.org/10.1093/jtm/tay062DOI Listing
February 2019
7 Reads

Perceptions of tick-borne encephalitis risk: a survey of travellers and travel clinics from Canada, Germany, Sweden and the UK.

J Travel Med 2019 Feb;26(Supplement_1):S10-S16

Department of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.

Background: While the worldwide endemicity of tick-borne encephalitis (TBE) has been increasing, a lack of awareness of the risks of this life-threatening disease may be leading to an underutilization of preventive measures among travellers to TBE-endemic regions. This study's objectives were to assess travellers' awareness of TBE and advice-seeking attitudes, and to evaluate practices of travel clinics regarding pre-travel advice.

Methods: We used an online questionnaire to identify individuals aged 18-65 years residing in the UK, Germany, Canada and Sweden, who had travelled to TBE-endemic countries between 2013 and 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jtm/tay063DOI Listing
February 2019
1 Read

Waning immunity after single dose yellow fever vaccination. Who needs a second shot?

J Travel Med 2018 Nov 23. Epub 2018 Nov 23.

Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, Massachusetts, USA; Faculty of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jtm/tay134DOI Listing
November 2018

Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines.

Vaccine 2018 Nov 21. Epub 2018 Nov 21.

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, United States. Electronic address:

The development of human rabies vaccines has evolved dramatically from the first crude nerve tissue vaccine produced then administered in the presence of Louis Pasteur in 1885. New cell culture technology has enabled highly potent and well-tolerated rabies vaccines to be produced that have reduced the volume and number of doses required to save human lives after exposure. However, these highly potent vaccines are still unaffordable to many patients living at risk of exposure on a daily basis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2018.10.103DOI Listing
November 2018

Safe Living Following Solid Organ Transplantation.

Authors:
Barbra M Blair

Surg Clin North Am 2019 Feb;99(1):153-161

Division of Infectious Diseases, Beth Israel Deaconess Medical Center, 110 Francis Street, Suite GB, Boston, MA 02215, USA. Electronic address:

Living safely after organ transplantation starts before transplant and continues after transplant. To minimize a solid organ transplant (SOT) recipient's risk for infection and risk for injury, it is important to plan for numerous potential exposures after transplant. These include potential exposure to others with viral or bacterial illness, potential exposure to food and water sources, participation in recreational activities, resuming sexual activity, living with pets, and opportunities for travel, especially internationally. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suc.2018.09.011DOI Listing
February 2019
1 Read

Changes to country-specific hepatitis A travel vaccination recommendation for UK travellers in 2017-responding to a vaccine shortage in the national context.

Public Health 2018 Nov 12. Epub 2018 Nov 12.

National Travel Health Network and Centre (NaTHNaC), University College London Hospital NHS Foundation Trust, London, UK.

Objectives: A routine review of hepatitis A travel vaccination recommendations was brought forward in June 2017 due to hepatitis A vaccine shortages and a concurrent outbreak in men who have sex with men (MSM). There were three objectives: first, to document the review process for changing the recommendations for the UK travellers in June 2017. Second, to study the impact of these changes on prescribing in general practice in 2017 compared with the previous 5 years. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00333506183030
Publisher Site
http://dx.doi.org/10.1016/j.puhe.2018.09.017DOI Listing
November 2018
10 Reads

Heterologous Boost Following Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.

Front Immunol 2018 30;9:2439. Epub 2018 Oct 30.

Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Adults are the leading population affected by tuberculosis (TB) epidemic and death. Developing an effective vaccine against adult TB is urgently needed. Bacillus Calmette-Guerin (BCG) prime-heterologous boost strategy has been explored extensively to protect adults against primary TB infection, but the majority of experimental regimens have not improved the protection primed by the BCG vaccine. Read More

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02439
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218689PMC
October 2018
11 Reads

Bacterial respiratory carriage in French Hajj pilgrims and the effect of pneumococcal vaccine and other individual preventive measures: A prospective cohort survey.

Travel Med Infect Dis 2018 Nov 8. Epub 2018 Nov 8.

Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France. Electronic address:

Background: Viral respiratory tract infections are known to be common in Hajj pilgrims while the role of bacteria is less studied.

Methods: Clinical follow-up, adherence to preventive measures and PCR-based pharyngeal bacterial carriage pre- and post-Hajj, were assessed in a cohort of 119 French Hajj pilgrims.

Results: 55% had an indication for pneumococcal vaccination. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14778939183038
Publisher Site
http://dx.doi.org/10.1016/j.tmaid.2018.10.021DOI Listing
November 2018
9 Reads

Epidemiological and Clinical Features of Typhi Infection Among Adult Patients in Qatar: A Hospital-based Study.

Oman Med J 2018 Nov;33(6):468-472

Department of Microbiology, Hamad General Hospital, Doha, Qatar.

Objectives: We sought to describe the epidemiological and clinical features of typhoid fever in Qatar.

Methods: We conducted a retrospective study of adult patients treated for typhoid fever at Hamad General Hospital and Alkhor Hospital between 2005 and 2012.

Results: The mean age of the 354 patients enrolled in the study was 28. Read More

View Article

Download full-text PDF

Source
http://omjournal.org/articleDetails.aspx?coType=1&aId=23
Publisher Site
http://dx.doi.org/10.5001/omj.2018.87DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206420PMC
November 2018
10 Reads

Human papillomavirus vaccine uptake among young gay and bisexual men who have sex with men with a time-limited targeted vaccination programme through sexual health clinics in Melbourne in 2017.

Sex Transm Infect 2018 Nov 8. Epub 2018 Nov 8.

Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia

Objective: In mid-2017, the Victorian Government funded a free time-limited human papillomavirus (HPV) vaccination catch-up programme for gay and bisexual men who have sex with men (MSM) aged up to 26 years through sexual health clinics or other immunisation centres. We aimed to examine the uptake of the HPV vaccine among young MSM attending the Melbourne Sexual Health Centre (MSHC).

Methods: MSM aged ≤26 attending MSHC between 27 April 2017 and 31 December 2017 were included in the analysis. Read More

View Article

Download full-text PDF

Source
http://sti.bmj.com/lookup/doi/10.1136/sextrans-2018-053619
Publisher Site
http://dx.doi.org/10.1136/sextrans-2018-053619DOI Listing
November 2018
3 Reads

Risk of Dengue in Travelers: Implications for Dengue Vaccination.

Curr Infect Dis Rep 2018 Oct 29;20(12):50. Epub 2018 Oct 29.

Department of Disease Control, London School of Hygiene and Tropical Medicine, Bloomsbury, UK.

Purpose Of Review: Dengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers.

Recent Findings: GeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11908-018-0656-3DOI Listing
October 2018
1 Read

National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries.

Travel Med Infect Dis 2019 Jan - Feb;27:33-38. Epub 2018 Oct 16.

Institute for Infection and Immunity, St George's, University of London, London, WC1E 7HU, UK; Section of Infectious Diseases & Immunity, Imperial College London, London, UK.

Background: Migrants may be underimmunised and at higher risk of vaccine-preventable diseases, yet there has been no comprehensive examination of what policies are currently implemented across Europe targeting child and adult migrants. We analysed vaccination policies for migrants in 32 EU/EEA countries and Switzerland.

Methods: Using framework analysis, we did a comparative analysis of national policies and guidelines pertaining to vaccination in recently arrived migrants through a systematic guideline and literature review and by approaching national experts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2018.10.011DOI Listing
October 2018
8 Reads

Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017.

Euro Surveill 2018 Oct;23(41)

Department of Internal Medicine/Infectious Diseases, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.

BackgroundMigrants within the European Union and European Economic Area (EU/EEA) may be underimmunised and lack documentation on previous vaccinations. We investigated approaches to vaccination in recently arrived adult and child migrants, and guideline availability and implementation. : Between March and May 2017, a national vaccination expert from every EU/EEA country and Switzerland completed an electronic questionnaire. Read More

View Article

Download full-text PDF

Source
https://www.eurosurveillance.org/content/10.2807/1560-7917.E
Publisher Site
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.41.1700772DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194906PMC
October 2018
4 Reads

The current syndemic in Venezuela: Measles, malaria and more co-infections coupled with a breakdown of social and healthcare infrastructure. Quo vadis?

Travel Med Infect Dis 2019 Jan - Feb;27:5-8. Epub 2018 Oct 14.

Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Department of Infectious Diseases and Tropical Medicine, Clínica IDB Cabudare, Instituto de Investigaciones Biomédicas IDB, Barquisimeto, 3023, Lara, Venezuela; Infectious Diseases Research Branch, Venezuelan Science Incubator and the Zoonosis and Emerging Pathogens regional Collaborative Network, Cabudare, 3023, Lara, Venezuela; Laboratorio de Señalización Celular y Bioquímica de Parásitos, Instituto de Estudios Avanzados (IDEA), Caracas, Caracas, Venezuela.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14778939183032
Publisher Site
http://dx.doi.org/10.1016/j.tmaid.2018.10.010DOI Listing
October 2018
4 Reads

Diphtheria immunity in Australia: should we be concerned?

Infect Disord Drug Targets 2018 Oct 11. Epub 2018 Oct 11.

National Centre for Immunisation Research & Surveillance (NCIRS), The Children's Hospital at Westmead. Australia.

We report the results of the 2007 national serological survey of immunity to diphtheria in Australia to assess the impact of recent schedule changes on diphtheria immunity, and the adequacy of current policy in the context of increased international travel of people and pathogens. Residual sera (n =1656) collected opportunistically from Australian laboratories in 2007 were tested for diphtheria antibody levels using an enzyme immunoassay, with the protective threshold defined as ≥0.1 IU/mL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871526518666181011114834DOI Listing
October 2018
9 Reads

Measles vaccination status among Japanese university students participating in short-term study abroad programs.

Travel Med Infect Dis 2019 Jan - Feb;27:131-132. Epub 2018 Oct 9.

Department of Human Ecology, Graduate School of Environmental and Life Science, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2018.10.008DOI Listing
October 2018
1 Read

Factors associated with severity of tick-borne encephalitis: A prospective observational study.

Travel Med Infect Dis 2018 Nov - Dec;26:25-31. Epub 2018 Oct 6.

Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Background: Information on parameters associated with the severity of tick-borne encephalitis (TBE) is limited.

Methods: The association between 15 pre-defined parameters and the severity of TBE was evaluated in 717 consecutive adult patients diagnosed in Slovenia 2007-2012.

Results: Multivariable logistic regression showed that patient age (odds ratio, OR 1. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14778939183034
Publisher Site
http://dx.doi.org/10.1016/j.tmaid.2018.10.003DOI Listing
January 2019
13 Reads

Update on Vaccinating the Patient With Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol 2018 Dec;16(4):548-560

Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, 85 East Concord Street, Boston, MA, 02118, USA.

Purpose Of Review: Patients with inflammatory bowel disease (IBD) are at increased risk of infectious diseases independent of their immunosuppression status, and yet, studies suggest that this population is not receiving standard vaccinations at the same rate as the general population. This review seeks to understand why IBD patients may not be receiving recommended immunizations and to provide guidelines on vaccinating this vulnerable population.

Recent Findings: Inactive vaccines are recommended for patients with IBD regardless of immunosuppression status due to the increased risk for many vaccine-preventable illnesses. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11938-018-0200-4
Publisher Site
http://dx.doi.org/10.1007/s11938-018-0200-4DOI Listing
December 2018
14 Reads

Drug-free holidays: Compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis in Australian travellers.

Clin Infect Dis 2018 Oct 3. Epub 2018 Oct 3.

Dr Deb The Travel Doctor, Travel Medicine Alliance, Brisbane, Australia.

Background: Poor compliance with chemoprophylaxis is a major contributing factor to the risk of malaria in travellers. Pre-travel chemoprophylaxis may improve compliance by enabling 'drug-free holidays'. The standard treatment dose of atovaquone/proguanil (250mg/100mg, 4 tablets/day for 3 days) provides protection against malaria for at least 4 weeks, and could therefore potentially be used for pre-travel chemoprophylaxis. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/cid/advance-article/doi/10.1093/cid
Publisher Site
http://dx.doi.org/10.1093/cid/ciy854DOI Listing
October 2018
9 Reads

Should travellers be offered vaccination against the dengue virus?

Travel Med Infect Dis 2019 Jan - Feb;27:2-4. Epub 2018 Sep 27.

Department of Infectious Diseases, The Royal Hospital, Muscat, Oman; Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2018.09.006DOI Listing
September 2018
2 Reads

Report of the 20th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE): ISW-TBE: 20 years of commitment and still challenges ahead.

Authors:
Ursula Kunze

Ticks Tick Borne Dis 2019 01 7;10(1):13-17. Epub 2018 Aug 7.

Institute for Social Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, A-1090, Vienna, Austria.

The 20th Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) - a group of neurologists, general practitioners, clinicians, travel physicians, virologists, pediatricians, ecologists, and epidemiologists - was held under the theme "ISW-TBE: 20 years of commitment & still challenges ahead". On the occasion of the 20 anniversary of the ISW-TBE several key topics in TBE were extensively discussed, among them current epidemiological developments and investigations, expansion of risk areas, clinical aspects and cases, traveling and mobility, and latest news on TBE vaccination. The main goals that have been achieved by the ISW-TBE so far are, among others, an increased awareness in endemic and non-endemic countries, an increase of vaccination rates in various countries, getting TBE acknowledged and established as a travel-related risk, and building contact with the European Centre for Disease Prevention and Control. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S1877959X183032
Publisher Site
http://dx.doi.org/10.1016/j.ttbdis.2018.08.004DOI Listing
January 2019
9 Reads

Pneumococcal disease during Hajj and Umrah: Research agenda for evidence-based vaccination policy for these events.

Travel Med Infect Dis 2018 Aug 23. Epub 2018 Aug 23.

The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.

Pneumococcal disease is an important cause of morbidity and mortality worldwide with a significant financial burden. Pneumococcal vaccines are available and recommended in many countries for at-risk populations including young children, the elderly and those with underlying medical conditions. The Hajj and Umrah mass gatherings attract millions of Muslim pilgrims to the Kingdom of Saudi Arabia each year. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2018.08.005DOI Listing
August 2018
5 Reads

S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease.

J Travel Med 2019 Jan;26(1)

Department of Infectious Diseases, LUMC, Leiden, The Netherlands.

Introduction: Typhoid fever is a global health problem, causing significant morbidity and mortality. Currently, the most widely used vaccine is the typhoid Vi capsular polysaccharide (Vi-PS) vaccine. While epidemiological studies on its efficacy have been performed in children in endemic countries, there are no efficacy studies evaluating its use in travel medicine. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jtm/tay073DOI Listing
January 2019
3 Reads

The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis.

Vaccine 2018 09 16;36(39):5832-5845. Epub 2018 Aug 16.

Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1100AZ Amsterdam, Amsterdam, The Netherlands. Electronic address:

Introduction: Patients with a weakened immune system due to immunosuppressive treatment are at increased risk of infection with Streptococcus pneumoniae. Although pneumococcal vaccination is highly recommended for those patients, the effectiveness of pneumococcal vaccination in this population remains largely unknown. Therefore, the objective of this PROSPERO-registered systematic review and meta-analysis was to evaluate the effect of the most commonly prescribed immunosuppressive agents such as azathioprine, methotrexate, anti-Tumor Necrosis Factor α (TNFα), or rituximab, on the initial serologic response to pneumococcal vaccination in patients with auto-immune disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2018.07.039DOI Listing
September 2018
18 Reads

Vaccination coverage and associated factors among children aged 12 - 23 months in Northwest Ethiopia.

Hum Vaccin Immunother 2018 5;14(10):2348-2354. Epub 2018 Sep 5.

a College of Medicine and Health Sciences, Department of Adult Health Nursing , Bahir Dar University , Bahir Dar , Ethiopia.

Background: Full vaccination coverage has been identified as the foundation for the prevention of morbidity and mortality from the childhood illnesses. However, a significant number of children do not get recommended vaccinations. The problem is much worse in low-income countries with varied figures and evidence gap. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/21645515.2018.1
Publisher Site
http://dx.doi.org/10.1080/21645515.2018.1502528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284506PMC
September 2018
25 Reads

Letter to the editor concerning comments by Hamer and Chen on Japanese encephalitis: vaccine options and timing of pre-travel vaccination.

Authors:
Lars Lindquist

J Travel Med 2018 Aug;25(1)

Department of Medicine H7, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jtm/tay048DOI Listing

Immunizations in Athletes.

Sports Health 2018 Sep/Oct;10(5):427-433. Epub 2018 Jul 30.

St Dominic's Family and Sports Medicine, Flowood, Mississippi.

Context: Immunizations are a cornerstone of preventive care and an important consideration for team physicians caring for athletes.

Evidence Acquisition: A PubMed search was performed from August 2016 through May 2017 as well as a website review of the Centers for Disease Control and Prevention, World Health Organization, and Immunization Action Coalition.

Study Design: Clinical review. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1941738118788279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116102PMC
September 2018
5 Reads